Literature DB >> 16950881

Evaluation of disulfide reduction during receptor-mediated endocytosis by using FRET imaging.

Jun Yang1, Hongtao Chen, Iontcho R Vlahov, Ji-Xin Cheng, Philip S Low.   

Abstract

Despite functional evidence for disulfide bond-reducing activity in endosomal compartments, the mechanistic details pertaining to such process (e.g., kinetics and sites of disulfide reduction) remain largely controversial. To address these questions directly, we have synthesized a previously uncharacterized fluorescent folate conjugate, folate-(BODIPY FL)-SS-rhodamine (folate-FRET), that changes fluorescence from red to green upon disulfide bond reduction. Using this construct, we have observed that disulfide reduction: (i) occurs with a half-time of 6 h after folate-FRET endocytosis, (ii) begins in endosomes and does not depend significantly on redox machinery located on the cell surface or within the lysosome or the Golgi apparatus, (iii) occurs independently of endocytic vesicle trafficking along microtubules, and (iv) yields products that are subsequently sorted into distinct endosomes and trafficked in different directions. Finally, colocalization of folate and transferrin receptors suggest that conclusions derived from this study may apply to other endocytic pathways.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16950881      PMCID: PMC1564263          DOI: 10.1073/pnas.0601455103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

Review 1.  Targeted drug conjugates: principles and progress.

Authors:  M C Garnett
Journal:  Adv Drug Deliv Rev       Date:  2001-12-17       Impact factor: 15.470

2.  GPI-anchored proteins are delivered to recycling endosomes via a distinct cdc42-regulated, clathrin-independent pinocytic pathway.

Authors:  Shefali Sabharanjak; Pranav Sharma; Robert G Parton; Satyajit Mayor
Journal:  Dev Cell       Date:  2002-04       Impact factor: 12.270

3.  Oxidizing potential of endosomes and lysosomes limits intracellular cleavage of disulfide-based antibody-drug conjugates.

Authors:  Cary D Austin; Xiaohui Wen; Lewis Gazzard; Christopher Nelson; Richard H Scheller; Suzie J Scales
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-01       Impact factor: 11.205

4.  Prostate stem cell antigen as therapy target: tissue expression and in vivo efficacy of an immunoconjugate.

Authors:  Sarajane Ross; Susan D Spencer; Ilona Holcomb; Christine Tan; JoAnne Hongo; Brigitte Devaux; Linda Rangell; Gilbert A Keller; Peter Schow; Rita M Steeves; Robert J Lutz; Gretchen Frantz; Kenneth Hillan; Franklin Peale; Patti Tobin; David Eberhard; Mark A Rubin; Laurence A Lasky; Hartmut Koeppen
Journal:  Cancer Res       Date:  2002-05-01       Impact factor: 12.701

5.  Folate receptor specific anti-tumor activity of folate-mitomycin conjugates.

Authors:  Joseph A Reddy; Elaine Westrick; Iontcho Vlahov; Stephen J Howard; Hari Krishna Santhapuram; Christopher P Leamon
Journal:  Cancer Chemother Pharmacol       Date:  2005-12-06       Impact factor: 3.333

Review 6.  Perspectives on anti-HER monoclonal antibodies.

Authors:  Malcolm Ranson; Mark X Sliwkowski
Journal:  Oncology       Date:  2002       Impact factor: 2.935

7.  GPI anchoring leads to sphingolipid-dependent retention of endocytosed proteins in the recycling endosomal compartment.

Authors:  S Chatterjee; E R Smith; K Hanada; V L Stevens; S Mayor
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

8.  Optical imaging of metastatic tumors using a folate-targeted fluorescent probe.

Authors:  Michael D Kennedy; Karim N Jallad; David H Thompson; Dor Ben-Amotz; Philip S Low
Journal:  J Biomed Opt       Date:  2003-10       Impact factor: 3.170

9.  Evaluation of folate conjugate uptake and transport by the choroid plexus of mice.

Authors:  Michael D Kennedy; Karim N Jallad; June Lu; Philip S Low; Dor Ben-Amotz
Journal:  Pharm Res       Date:  2003-05       Impact factor: 4.200

Review 10.  Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia.

Authors:  Francis Giles; Elihu Estey; Susan O'Brien
Journal:  Cancer       Date:  2003-11-15       Impact factor: 6.860

View more
  80 in total

1.  The transduction of Coxsackie and Adenovirus Receptor-negative cells and protection against neutralizing antibodies by HPMA-co-oligolysine copolymer-coated adenovirus.

Authors:  Chung-Huei K Wang; Leslie W Chan; Russell N Johnson; David S H Chu; Julie Shi; Joan G Schellinger; André Lieber; Suzie H Pun
Journal:  Biomaterials       Date:  2011-09-28       Impact factor: 12.479

2.  Microscale screening of antibody libraries as maytansinoid antibody-drug conjugates.

Authors:  Kalli C Catcott; Molly A McShea; Carl Uli Bialucha; Kathy L Miller; Stuart W Hicks; Parmita Saxena; Thomas G Gesner; Mikias Woldegiorgis; Megan E Lewis; Chen Bai; Michael S Fleming; Seth A Ettenberg; Hans K Erickson; Nicholas C Yoder
Journal:  MAbs       Date:  2016-01-11       Impact factor: 5.857

Review 3.  Targeting polymer therapeutics to bone.

Authors:  Stewart A Low; Jindřich Kopeček
Journal:  Adv Drug Deliv Rev       Date:  2012-01-28       Impact factor: 15.470

Review 4.  New strategies for fluorescent probe design in medical diagnostic imaging.

Authors:  Hisataka Kobayashi; Mikako Ogawa; Raphael Alford; Peter L Choyke; Yasuteru Urano
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

5.  Glutathione-Responsive Prodrug Nanoparticles for Effective Drug Delivery and Cancer Therapy.

Authors:  Xiang Ling; Jiasheng Tu; Junqing Wang; Aram Shajii; Na Kong; Chan Feng; Ye Zhang; Mikyung Yu; Tian Xie; Zameer Bharwani; Bader M Aljaeid; Bingyang Shi; Wei Tao; Omid C Farokhzad
Journal:  ACS Nano       Date:  2018-12-04       Impact factor: 15.881

6.  Cholesterol level regulates endosome motility via Rab proteins.

Authors:  Hongtao Chen; Jun Yang; Philip S Low; Ji-Xin Cheng
Journal:  Biophys J       Date:  2007-11-02       Impact factor: 4.033

7.  Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands.

Authors:  Wei He; Sumith A Kularatne; Kimberly R Kalli; Franklyn G Prendergast; Robert J Amato; George G Klee; Lynn C Hartmann; Philip S Low
Journal:  Int J Cancer       Date:  2008-10-15       Impact factor: 7.396

8.  Glutathione-Scavenging Poly(disulfide amide) Nanoparticles for the Effective Delivery of Pt(IV) Prodrugs and Reversal of Cisplatin Resistance.

Authors:  Xiang Ling; Xing Chen; Imogen A Riddell; Wei Tao; Junqing Wang; Geoffrey Hollett; Stephen J Lippard; Omid C Farokhzad; Jinjun Shi; Jun Wu
Journal:  Nano Lett       Date:  2018-06-19       Impact factor: 11.189

9.  Synthesis and characterization of biodegradable HPMA-oligolysine copolymers for improved gene delivery.

Authors:  Rob S Burke; Suzie H Pun
Journal:  Bioconjug Chem       Date:  2010-01       Impact factor: 4.774

10.  Regulation of hepatitis B virus infection by Rab5, Rab7, and the endolysosomal compartment.

Authors:  Alina Macovei; Catalina Petrareanu; Catalin Lazar; Paula Florian; Norica Branza-Nichita
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.